Effect of berberine on pharmacokinetics of digoxin after oral administration to rats

Zhongguo Zhongyao Zazhi

Volumn 36, Issue 7, 2011, Pages 918-921

  Ju, Yang ^a   Qiu, Wen ^a   Jiang, Xuehua ^b   Liu, Changxiao ^c  

^a LANZHOU UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH   (China)

Author keywords

Berberine; Digoxin; P gp; Pharmacokinetics

Indexed keywords

BERBERINE; DIGOXIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; NONHUMAN; RADIOIMMUNOASSAY; RAT;

ADMINISTRATION, ORAL; ANIMALS; BERBERINE; DIGOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; RATS; RATS, WISTAR; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 79959960566     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20110721     Document Type: Article

References (17)

1. Taylor C T, Baird A W. Berberine inhibition of electrogenicion transport in rat colon [J]. Br J Pharmacol, 1995, 116(6):2667.
2. Kaneda Y, Torii M, Tanaka T, et al. In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis [J]. Ann Trop Med Parasite, 1991, 85(4):417.
3. Iizuka N, Miyamoto K, Okita K, et al. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines [J]. Cancer Lett, 2000, 148(1):19.
4. Ckless K, Schlottfeldt J L, Pasqual M, et al. Inhibition of in vitro lymphocyte trans formation by the isoquinoline alkaloid berberine [J]. J Pharm Pharmacol, 1995, 47(12A):1029.
5. Sánchez-Chapula J. Increase in action potential duration and inhibition of the delayed rectifier outward current IK by berberine in cat ventricular myocytes [J]. Br J Pharmacol, 1996, 117(7):1427.
6. Wu X, Li Q, Xin H, et al. Effects of berberine on the blood concentration of cyclo-sporine A in renal transplanted recipients: chnical and pharmacokinetics study [J]. Eur J Clin Pharmacol, 2005, 61(8):567.
7. Lin H L, Liu T Y, Lui W Y, et al. Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells [J]. Cancer, 1999, 85(9):1937.
8. He L, Liu G Q. Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells [J]. Acta Pharmacol Sin, 2002, 23(7):591.
9. Kurzawski M, Bartnicka L, Florczak M, et al. Impact of ABCB1 (MDR1) gene polymorphism and P-glycoprotein inhibitors on digoxin serum concentration in congestive heart failure patients [J]. Pharmacol Rep, 2007, 59(1):107.
10. Gurley B J, Swain A, Barone G W, et al. Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans [J]. Drug Metab Dispos, 2007, 35(2):240.
11. Ghanem C I, Gómez P C, Arana M C, et al. Induction of rat intestinal P-glycoprotein by spironolactone and its effect on absorption of orally administered digoxin [J]. J Pharmacol Exp Ther, 2006, 318(3):1146.
12. Becquemont L, Glaeser H, Drescher S, et al. Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans [J]. Clin Pharmacol Ther, 2006, 79(5):449.
13. Peng S X, Ritchie D M, Cousineau M, et al. Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministeration of biochanin A [J]. Pharm Sci, 2006, 95(9): 1984.
14. Yoshida N, Takagi A, Kitazawa H, et al. Effects of citronellal, a monoterpenoid in Zanthoxyli Fructus, on the intestinal absorption of digoxin in vitro and vivo [J]. Pharm Sci, 2006, 95(3): 552.
15. Matheny C J, Lamb M W, Brouwer K R, et al. Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation [J]. Pharmacotherapy, 2001, 21(7):778.
16. Hori R, Okamura N, Aiba T, et al. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney [J]. J Pharmacol ExpTher, 1993, 266(3):1620.
17. Lin H L, Liu T Y, Wu C W, et al. Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel [J]. Br J Cancer, 1999, 81(3):416.